​SinglePoint (SING) Begins Trading on the OTCQB Venture Market

Spotlight Companies |

SinglePoint Inc. (OTCQB:SING) , is pleased to announce it has been approved and is now trading on the OTCQB Venture Market, which requires a higher level of transparency and helps provide increased investor confidence through continued verification of information. Uplisting from the OTC Pink Open Market tier supports with the Company’s goals of increasing acquisition deal flow and having access to institutional investors both directly and through the open market.

“We are extremely pleased to be approved for OTCQB. It is a great step for SinglePoint as we continue to grow and build our footprint. Increased transparency and credibility will help broaden our shareholder base and provide additional exposure to the institutional investor community, ultimately contributing to increasing shareholder value,” states Greg Lambrecht CEO SinglePoint.

SinglePoint will continue to provide audited financials and plans to be fully reporting by filing a Form-10 or S-1 in the near future. The next step towards fully reporting will represent another initiative to further transparency, add credibility and increase exposure to investment banking firms.



About SinglePoint, Inc.

SinglePoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base. Through its subsidiary company SingleSeed, the company is providing products and services to the cannabis industry.

In the interest of full disclosure, we call the reader's attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
SING Singlepoint Inc 0.03 -0.00 -0.71 1,699,750

Comments

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…